| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1749-6632.1975.TB29197.X |
| P698 | PubMed publication ID | 52321 |
| P2093 | author name string | Feltkamp TE | |
| Aarden LA | |||
| de Groot ER | |||
| P2860 | cites work | Immunological studies concerning the nephritis of systemic lupus erythematosus | Q41510128 |
| Kinetoplast DNA. A unique macromolecular structure of considerable size and mechanical resistance | Q47382642 | ||
| An approach toward automation of antinuclear antibody (ANA) determination | Q47731139 | ||
| Antibodies to native DNA in systemic lupus erythematosus. A technique of rapid and quantitative determination | Q48000913 | ||
| Antigenicity of Trypanosome Nuclei : Evidence that DNA is not coupled to Histone in these Protozoa | Q58954581 | ||
| Characterization of Macromolecules by Constant Velocity Sedimentation | Q59053901 | ||
| Isotopes incorporated in the Nucleic Acids of Trypanosoma mega | Q59065012 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| Crithidia luciliae | Q5186585 | ||
| immunofluorescence microscopy | Q592324 | ||
| P304 | page(s) | 505-515 | |
| P577 | publication date | 1975-06-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique | |
| P478 | volume | 254 |
| Q40994557 | A Reappraisal of the Relationship between Subepidermal Immunoglobulin Deposits and DNA Antibodies in Systemic Lupus Erythematosus: A Study Using the Crithidia Luciliae Immunofluorescence Anti-DNA Assay |
| Q40894270 | A Solid Phase Enzyme-linked Immunosorbent Assay (ELISA) for the Demonstration of Antibodies against Denatured, Single-stranded DNA in Patient Sera |
| Q37950627 | A comparison of assays used for the detection of antibodies to DNA. |
| Q41876781 | A haemolytic plaque forming assay for identifying cells producing anti-DNA antibodies |
| Q68366286 | A human monoclonal IgM with autoantibody activities against heparan sulphate and the mitotic spindle |
| Q37311326 | A novel DNA/histone H4 peptide complex detects autoantibodies in systemic lupus erythematosus sera |
| Q72604091 | A simple immunofluorescence assay for C1q binding |
| Q39490503 | A simple, rapid ELISA method for the detection of DNA antibodies |
| Q48398078 | Activation of the genes for variant surface glycoproteins 117 and 118 in Trypanosoma brucei |
| Q38089261 | Advances in understanding newer autoantibodies and their role as biomarkers in systemic lupus erythematosus |
| Q35953274 | African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV) |
| Q66926672 | An enzyme-linked immunosorbent assay for antibodies to native and denatured DNA |
| Q40771003 | An immunofluorescent method usingcrithidia luciliae to detect antibodies to double-stranded DNA |
| Q64390447 | Anti-DNA antibodies of IgA class in patients with systemic lupus erythematosus |
| Q40559196 | Anti-DNA antibodies. Their idiotypes and SLE. |
| Q54144783 | Anti-DNA antibodies: problems in their study and interpretation. |
| Q72586540 | Anti-DNA antibody idiotypes in systemic lupus erythematosus |
| Q72650149 | Anti-Sm: its predictive value in systemic lupus erythematosus |
| Q35172078 | Anti-chromatin (anti-nucleosome) autoantibodies |
| Q36840223 | Anti-dsDNA: choice of assay in relation to clinical value |
| Q40703151 | Anti-dsdna and complement profiles as prognostic guides in systemic lupus erythematosus |
| Q38861405 | Anti-ssDNA and antinuclear antibodies in human malaria. |
| Q48819631 | Antibodies Against Central Nervous System Tissue (Anti-Cns) Detected by Elisa and Western Blotting: Marker Antibodies for Neuropsychiatric Manifestations in Connective Tissue Diseases |
| Q70281004 | Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease |
| Q64389352 | Antibodies to carbonic anhydrase in endometriosis: prevalence, specificity, and relationship to clinical and laboratory parameters |
| Q70379617 | Antibodies to dsDNA in connective tissue diseases measured by ultramicro enzyme-linked immunosorbent assay (ELISA) adapted to the chamber analytical technique (CAT) |
| Q69608468 | Antibodies to histones and disease activity in systemic lupus erythematosus: a comparative study with an enzyme-linked immunosorbent assay and immunoblotting |
| Q68182500 | Antibodies to native and denatured DNA. Quantitation using an immuno-slot-blot technique |
| Q67914546 | Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment |
| Q72669713 | Antibodies to single-stranded dna in patients with discoid lupus erythematosus |
| Q40673854 | Antibody to soluble nuclear antigens in dogs (German shepherd) with a lupus like syndrome |
| Q39410664 | Antigenic properties of a DNA-preparation from calf thymus used for the demonstration of anti-DNA |
| Q67268985 | Antigenicity of DNA induced by photoaddition of 8-methoxypsoralen |
| Q36386408 | Antinuclear antibodies (ANA) in Gordon setters with symmetrical lupoid onychodystrophy and black hair follicular dysplasia |
| Q39406225 | Antinuclear antibodies (ANA): Immunologic and clinical significance |
| Q21203675 | Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited |
| Q39823082 | Antinuclear antibodies in autoimmune disease. Significance and pathogenicity. |
| Q50417614 | Antinuclear antibodies in patients on lithium carbonate |
| Q33553751 | Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies |
| Q68825699 | Antinuclear antibodies in patients with systemic lupus erythematosus: a comparison of counterimmunoelectrophoresis and immunoblotting |
| Q52027368 | Antinuclear antibodies in psychiatric patients. |
| Q44849221 | Antinuclear antibody (ANA) substrates and quantification techniques |
| Q44545529 | Antinuclear antibody determinations in Ro(SSA)-positive, antinuclear antibody--negative lupus and Sjögren's syndrome patients |
| Q40106429 | Antipolynucleotide antibodies: The rheumatic connection |
| Q77492458 | Apoptosis and expression of soluble Fas mRNA in systemic lupus erythematosus |
| Q93634036 | Assessment of class-specific antibodies against denatured DNA in patients with systemic lupus erythematosus |
| Q35632045 | Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis |
| Q47980021 | Autoantibodies in sera of Thai patients with Plasmodium falciparum infection |
| Q77886844 | Autoantibodies specificity in acute anterior uveitis according to the presence of the HLA-B27 allele |
| Q40104710 | Autoantibodies to Nuclear Antigens (ANA): Their Immunobiology and Medicine |
| Q72717195 | Autoantibodies to decondensed sperm nuclear deoxyribonucleic acid in patients with antisperm antibodies and systemic lupus erythematosus detected by immunofluorescence flow cytometry |
| Q42107384 | Automated Evaluation of Crithidia luciliae Based Indirect Immunofluorescence Tests: A Novel Application of the EUROPattern-Suite Technology |
| Q34117915 | Cardiac damage in polymyositis associated with antibodies to tissue ribonucleoproteins |
| Q39964403 | Cell lines that express membrane-associated DNA for anti-DNA antibody detection |
| Q40823412 | Certain Polyclonal Antinuclear Antibodies Cross-React with the Surface Membrane of Human Lymphocytes and Granulocytes |
| Q72739248 | Changes in nuclear antigens during reactivation of chick erythrocyte nuclei in heterokaryons |
| Q70146485 | Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE) |
| Q36230008 | Characterization of somatically mutated S107 VH11-encoded anti-DNA autoantibodies derived from autoimmune (NZB x NZW)F1 mice |
| Q33933837 | Characterization of the SS-B (La) antigen in adenovirus-infected and uninfected HeLa cells |
| Q35501047 | Characterization of the expression-linked gene copies of variant surface glycoprotein 118 in two independently isolated clones of Trypanosoma brucei |
| Q44456348 | Characterization of two human monoclonal IgM antibodies that recognize nuclear lamins |
| Q38686357 | Childhood Lupus--Diagnosis and Management |
| Q70231666 | Circulating Immune Complexes in Systemic Scleroderma |
| Q41117653 | Circulating immune complex assays in patients with lupus and membranous glomerulonephritis |
| Q40661641 | Circulating immune complexes and antinuclear antibodies in juvenile rheumatoid arthritis |
| Q42835368 | Classifying lupus |
| Q34298818 | Clinical and serologic features of patients with polymyositis or dermatomyositis |
| Q36982346 | Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. |
| Q70232740 | Clinical profiles of patients with antibodies to nuclear ribonucleoprotein |
| Q39522985 | Clinico-Laboratory Aspects of Anti-Nuclear and Anti-Native DIMA Antibody Tests |
| Q54423282 | Cold-reactive antinuclear IgM. Diagnostic value in a case ANA-negative lupus erythematosus. |
| Q35625532 | Comparison and evaluation of different methodologies and tests for detection of anti-dsDNA antibodies on 889 Slovenian patients' and blood donors' sera |
| Q67324743 | Comparison of The Crithidia Lucilia, Millipore Filter, Farr, And Hemagglutination Methods For Detection of Antibodies to DNA |
| Q36369080 | Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2 |
| Q31148491 | Correlation of autoantibodies presence detected by IFA-anti-dsDNA, IFA-AMA and immunoblotting with corresponding data in clinical management of autoimmune diseases. |
| Q73676802 | Correlations of anti-dsDNA and anti-ribosomal P autoantibodies with lupus nephritis |
| Q50923513 | Cross-reactivity of anti-DNA antibodies with proteoglycans. |
| Q40682691 | Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes |
| Q81249367 | Cross-recognition between histones and La/SSB may account for anti-DNA reactivity in SLE patients |
| Q40311290 | Current perspectives on serological reactions in SLE patients. |
| Q40653505 | Detection and characterization of DNA-anti-DNA complexes in a patient with systemic lupus erythematosus |
| Q39373857 | Detection of Antibodies to Dna by Radioimmunoassay and Immunofluorescence |
| Q41121760 | Detection of anti-dsDNA as diagnostic tool |
| Q67471260 | Detection of antibodies to DNA: a technical assessment |
| Q36560773 | Detection of antibodies to dsDNA: an overview of laboratory assays |
| Q79171865 | Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus |
| Q40908753 | Differentiation between antibodies to protamines and somatic nuclear antigens by means of a comparative fluorescence study on swollen nuclei of spermatozoa and somatic cells |
| Q40734892 | Disease activity in systemic lupus erythematosus value of laboratory criteria |
| Q44360884 | Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody |
| Q49135230 | Disease manifestations of progressive systemic sclerosis: sensitivity and specificity |
| Q61974452 | Distinct antibody profile: a clue to primary antiphospholipid syndrome evolving into systemic lupus erythematosus? |
| Q42737245 | Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice |
| Q39369711 | Double-stranded DNA antibodies: a comparison of four methods of detection |
| Q39613404 | Effect of Levamisole on the lupus-like syndrome of mice and dogs |
| Q41227314 | Effect of fibronectin on the Crithidia luciliae test for anti-double-stranded DNA antibodies |
| Q69723297 | Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice |
| Q47752689 | Electrophysiological dysfunction induced by anti-ribosomal P protein antibodies injection into the lateral ventricle of the rat brain |
| Q45777757 | Elimination of soluble123I-labeled aggregates of IgG in patients with systemic lupus erythematosus. Effect of serum IgG and numbers of erythrocyte complement receptor type 1 |
| Q36348021 | Enhancing effect of H-2-linked NZW gene(s) on the autoimmune traits of (NZB X NZW)F1 mice |
| Q40237614 | Evaluation of a semiautomated prestandardized immunofluorescence test system for detection of anti-native deoxyribonucleic acid antibodies |
| Q42454135 | Evaluation of auto-antibodies in chronic mucocutaneous candidiasis without endocrinopathy |
| Q33518005 | Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies |
| Q86838725 | FSAP-mediated nucleosome release from late apoptotic cells is inhibited by autoantibodies present in SLE |
| Q34118867 | Family studies of congenital heart block associated with Ro antibody |
| Q33380972 | Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort |
| Q45172140 | Fine specificities of anti-nuclear antibodies in murine models of graft-versus-host disease |
| Q35868842 | Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies |
| Q35589316 | Five groups of antigenic determinants on DNA identified by monoclonal antibodies from (NZB X NZW)F1 and MRL/Mp-lpr/lpr mice |
| Q39362189 | Follow-up study of 6 children presenting with a MCTD-like syndrome |
| Q53559916 | Frequency of anti-DNA antibody producing cells from normals and patients with systemic lupus erythematosus |
| Q47823014 | Gene immunization may induce secondary antibodies reacting with DNA. |
| Q71040077 | Genetic regulation of erythrocyte autoantibody production in New Zealand black mice |
| Q71102227 | Genetic regulation of the class conversion of dsDNA-specific antibodies in (NZB X NZW)F1 hybrid |
| Q79857260 | Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis |
| Q67297495 | Growth of chromosome ends in multiplying trypanosomes |
| Q33557297 | HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease |
| Q46082516 | Hemoflagellate kinetoplasts and the diagnosis of SLE |
| Q40887620 | Hereditary C2 deficiency and systemic lupus erythematosus associated with severe glomerulonephritis |
| Q46559633 | High-titer antichromatin antibody is associated with proliferative class IV of lupus nephritis. |
| Q67485723 | Histone and DNA detection in swollen spermatozoa and somatic cells, by immunofluorescence |
| Q35579325 | Human autoantibodies to poly(adenosine diphosphate-ribose) polymerase |
| Q33731760 | Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. |
| Q40962844 | Identification of antinative DNA antibodies in cryoglobulinemic states |
| Q52904015 | Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay. |
| Q67975301 | IgG human monoclonal anti-DNA autoantibodies from patients with systemic lupus erythematosus |
| Q35638637 | Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis |
| Q72425102 | Immune-complex glomerulopathy in patients treated with captopril |
| Q35574002 | Immune-mediated fever in the dog. Occurrence of antinuclear antibodies, rheumatoid factor, tumor necrosis factor and interleukin-6 in serum |
| Q33561874 | Immunoblotting profiles in 55 systemic lupus erythematosus sera lacking precipitating antibodies to extractable nuclear antigens |
| Q41105460 | Immunochemical characteristics of antibodies to DNA in patients with active systemic lupus erythematosus |
| Q33551990 | Immunoglobulin classes in skin basement membrane in systemic lupus erythematosus: clinical significance and comparison with classes of serum anti-DNA antibodies |
| Q33488126 | Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity |
| Q68810847 | Immunological investigations in individuals with selective IgA deficiency |
| Q61877221 | Immunologische Untersuchungen beim primären Offenwinkelglaukom |
| Q39084258 | Immunology of DNA. I. The influence of reaction conditions on the farr assay as used for the detection of anti-ds DNA |
| Q40790341 | Immunology of DNA. VI. The effect of mercaptans on IgG and IgM anti-dsDNA |
| Q70358811 | Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus |
| Q33676884 | In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones |
| Q44649209 | Induction of anticentromere antibody in patients receiving treatment with D-penicillamine |
| Q41941349 | Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. |
| Q54495364 | Influence of pH on the detection of low- and high-avidity anti-dsDNA |
| Q34455710 | Interferon treatment of NZB mice: accelerated progression of autoimmune disease |
| Q71683959 | Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis |
| Q69649360 | Is MCTD a distinct entity? Comparison of clinical and laboratory findings in MCTD, SLE, PSS, and RA patients |
| Q42266209 | Laboratory tests in the rheumatic disease |
| Q72091442 | Late treatment of murine lupus erythematosus with dactinomycin. II. C1 and antibody to DNA |
| Q36626290 | Local immune complexes and inflammatory response in patients with chronic interstitial pulmonary disorders associated with collagen vascular diseases |
| Q72621027 | Lupus Erythematosus: Laboratory Testing and Clinical Subsets in the Evaluation of Patients |
| Q34122085 | Lupus autoantibodies to native DNA cross-react with the A and D SnRNP polypeptides |
| Q40373825 | Lupus hepatitis: an under-recognized disease feature associated with autoantibodies to ribosomal P. |
| Q46945978 | Lupus in children in Tunisia |
| Q37201337 | Lupus nephritis: clinicopathological study of 162 cases in Thailand |
| Q64388733 | Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus |
| Q43270423 | Male gender results in more severe lupus nephritis |
| Q34300657 | Male-only systemic lupus |
| Q71461708 | Measurement of low avidity anti-dsDNA by the Crithidia luciliae test and the PEG assay |
| Q26781272 | Mechanisms of Kidney Injury in Lupus Nephritis - the Role of Anti-dsDNA Antibodies |
| Q68129909 | Mercury induced antinuclear antibodies in mice: characterization and correlation with renal immune complex deposits |
| Q66944185 | Microscopic hematuria in schoolchildren: Epidemiology and clinicopathologic evaluation |
| Q24633473 | Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant |
| Q28343236 | Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis |
| Q44060283 | Murine monoclonal antibodies to DNA. A comparison of MRL/lpr NZB/W and chronically graft-versus-host-diseased mice |
| Q83895416 | Myth and reality: practical test system for the measurement of anti-DNA antibodies in the diagnosis of systemic lupus erythematosus (SLE) |
| Q70877444 | Neonatal Lupus Erythematosus: New Serologic Findings |
| Q70220751 | Neurological features in overlap syndrome |
| Q39828436 | Newly defined serologic systems in systemic lupus erythematosus and dermatomyositis |
| Q69882685 | Nonlinear behaviour of anti-dsDNA antibodies in dilution experiments using ultramicro ELISA |
| Q40643161 | Nuclear deposits of immunoglobulins in skin of patients with systemic lupus erythematosus |
| Q52871905 | Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus. |
| Q40725594 | Occurrence of antibodies to single-stranded DNA in ANA negative patients |
| Q72635040 | On the Biochemical Nature of the 'Sm' Nucleoplasmic Antigen |
| Q73171118 | Overexpression of Frat1 in transgenic mice leads to glomerulosclerosis and nephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression |
| Q33564386 | Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response? |
| Q34572296 | Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice |
| Q43717482 | Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. |
| Q64390699 | Phagocytosis and degradation of DNA‐anti‐DNA complexes by human phagocytes I. Assay conditions, quantitative aspects and differences between human blood monocytes and neutrophils |
| Q58831879 | Platelet cationic proteins are present in glomeruli of lupus nephritis patients |
| Q33555419 | Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort |
| Q35824462 | Predictive value of autoantibodies for activity of systemic lupus erythematosus |
| Q33448450 | Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort |
| Q37659608 | Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX. |
| Q35221874 | Prevalence of acne rosacea in a rheumatic skin disease subspecialty clinic |
| Q33563796 | Prevalence of antiphospholipid antibodies in patients with fetal loss |
| Q64388631 | Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus |
| Q39576263 | Procainamide-Induced Lupus Erythematosus-like Syndrome in Relation to Acetylator Phenotype and Plasma Levels of Procainamide |
| Q39863980 | Prolidase deficiency breaks tolerance to lupus-associated antigens |
| Q70351381 | Prospects and Problems in the Definition and Standardization of Immunofluorescence. I. Present Levels of Reproducibility and Disease Specificity of Antinuclear Antibody Tests a |
| Q33455990 | Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort |
| Q52922059 | Psychiatric symptoms before systemic lupus erythematosus is diagnosed. |
| Q69925201 | Quantitation of antibodies to nucleoribonucleoprotein by ELISA: relation between antibody levels and disease activity in patients with connective tissue disease |
| Q72113335 | Quantitative studies of the interaction of 3H-dsDNA/anti-DNA immune complexes with complement: comparison and evaluation of the Raji cell, the solution phase C1Q, and the red blood cell linked complement fixation radioimmunoassays |
| Q70176992 | Reactivity patterns of anti-phospholipid antibodies in systemic lupus erythematosus sera in relation to erythrocyte binding and complement activation |
| Q72764401 | Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La |
| Q72675625 | Reproducibility studies for anti-DNA antibody detection in systemic lupus erythematosus and related diseases. Fiax fluorometric immunoassay and farr radioimmunoassay |
| Q33583899 | Respiratory symptoms, lung function, and pneumoconiosis among self employed dental technicians. |
| Q70933409 | Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity? |
| Q47850502 | Rheumatoid hyperviscosity: analysis of a patient with intermediate complexes that block other autoantibodies and a review of the literature |
| Q50803898 | Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency. |
| Q70183978 | SLE like syndrome and functional deficiency of C1q in members of a large family |
| Q40975386 | SLE: The Value of Immunological Tests and Aspects of Management |
| Q40555883 | Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients |
| Q38356854 | Secondary structure in denatured DNA is responsible for its reaction with antinative DNA antibodies of systemic lupus erythematosus sera |
| Q47176485 | Segregation of lymphocyte low-molecular-weight DNA and antinuclear-antibodies in a family with systemic lupus erythematosus in first cousins |
| Q31129756 | Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV). |
| Q54073818 | Sequential studies of complement activation in systemic lupus erythematosus. |
| Q47910742 | Sera of patients with systemic lupus erythematosus react with plasmodial antigens and can inhibit the in vitro growth of Plasmodium falciparum |
| Q69876832 | Serologic and clinical features of patients with discoid lupus erythematosus: relationship of antibodies to single-stranded deoxyribonucleic acid and of other antinuclear antibody subsets to clinical manifestations |
| Q72085943 | Serum antibodies in connective tissue diseases |
| Q48220936 | Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders |
| Q40720274 | Serum complement abnormalities in the antinuclear antibody-positive relatives of children with systemic lupus erythematosus |
| Q33484542 | Severe thrombocytopenia in mixed connective tissue disease |
| Q42613879 | Shared early autoantibody recognition events in the development of anti-Sm B/B' in human lupus |
| Q64390002 | Shifts of anti-Sm-specific antibodies in patients with systemic lupus erythematosus: Analysis by counter-immunoelectrophoresis, immunoblotting and RNA-immunoprecipitation |
| Q72749846 | Sjöugren's syndrome influence of multiple hla-d region alloantigens on clinical and serologic expression |
| Q69045037 | Specific suppression of anti-DNA production in vitro |
| Q36090316 | Spontaneous hypertension and hypertensive renal disease in the fawn-hooded rat |
| Q37074182 | Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response |
| Q68929209 | Subacute cutaneous lupus erythematosus. Clinical, serologic, and immunogenetic studies of forty-nine patients seen in a nonreferral setting |
| Q36826930 | Systemic and anti-neuronal auto-antibodies in patients with paraneoplastic neurological disease |
| Q37327039 | Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus |
| Q46329612 | Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity |
| Q44148062 | Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage |
| Q69865356 | Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients |
| Q43989009 | Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis |
| Q46430510 | Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture |
| Q28588979 | T-bet regulates IgG class switching and pathogenic autoantibody production |
| Q37995556 | TLR7 and TLR9 in SLE: when sensing self goes wrong |
| Q67483556 | The Clinical Significance of Measuring Different Anti-dsDNA Antibodies by Using the Farr Assay, an Enzyme Immunoassay and a Crithidia luciliae Immunofluorescence Test |
| Q24678474 | The Crithidia luciliae kinetoplast immunofluorescence test in systemic lupus erythematosus |
| Q39373869 | The Detection of Anti-Dna and Dna/Anti-Dna Complexes |
| Q70286031 | The Relationship of Renal Histopathological Lesions to Immunoglobulin Classes and Complement Fixation of Anti-Native DNA Antibodies in Systemic Lupus Erythematosus |
| Q70475748 | The coexistence of systemic lupus erythematosus and psoriasis |
| Q56904544 | The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells |
| Q41573737 | The inactivation and reactivation of an expression-linked gene copy for a variant surface glycoprotein in Trypanosoma brucei |
| Q38219271 | The measurement of anti-DNA activity in the sera of patients with systemic lupus erythematosus: theoretical and practical considerations |
| Q33446848 | The prevalence and clinical associations of the lupus anticoagulant in systemic lupus erythematosus. |
| Q72073782 | The role of antibodies directed against double-stranded DNA in the manifestations of systemic lupus erythematosus in childhood |
| Q35856009 | The type of dietary fat affects the severity of autoimmune disease in NZB/NZW mice |
| Q24682977 | The use of laboratory tests in the diagnosis of SLE |
| Q36403146 | Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus |
| Q36840264 | Treatment of systemic lupus erythematosus: which options do we have for therapy regimens? |
| Q64390638 | Use of nuclear antigen-coated red cells in hemolytic plaque assays |
| Q64390714 | [Antinuclear antibodies in diagnosis of rheumatic diseases (author's transl)] |
| Q82626722 | [Antinuclear antibodies] |
| Q53864169 | [Diagnostic value of antinuclear antibodies in internal medicine. Retrospective analysis of 1734 cases]. |
| Q64390689 | [The Crithidia luciliae immunofluorescence test for detection of antibodies to double-stranded DNA (author's transl)] |
| Q68157669 | [The diagnostic value of anti-DNA antibodies depends on the technic used for their detection] |
Search more.